BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6261783)

  • 1. Interaction of fibrinogen with its platelet receptor: kinetics and effect of pH and temperature.
    Marguerie GA; Plow EF
    Biochemistry; 1981 Mar; 20(5):1074-80. PubMed ID: 6261783
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets.
    Kornecki E; Niewiarowski S; Morinelli TA; Kloczewiak M
    J Biol Chem; 1981 Jun; 256(11):5696-701. PubMed ID: 6263888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interaction of fibrinogen with platelets. Review].
    Regañón E; Aznar J; Vila V
    Sangre (Barc); 1985; 30(4-A):449-57. PubMed ID: 3000005
    [No Abstract]   [Full Text] [Related]  

  • 4. Exposure of fibrinogen receptor on human platelets by proteolytic enzymes.
    Niewiarowski S; Budzynski AZ; Morinelli TA; Brudzynski TM; Stewart GJ
    J Biol Chem; 1981 Jan; 256(2):917-25. PubMed ID: 6256372
    [No Abstract]   [Full Text] [Related]  

  • 5. Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain.
    Kloczewiak M; Timmons S; Hawiger J
    Biochem Biophys Res Commun; 1982 Jul; 107(1):181-7. PubMed ID: 6289817
    [No Abstract]   [Full Text] [Related]  

  • 6. The fibrinogen-dependent pathway of platelet aggregation.
    Marguerie GA; Plow EF
    Ann N Y Acad Sci; 1983 Jun; 408():556-66. PubMed ID: 6307106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of fibrinogen molecules to pig platelets and their membranes.
    Cierniewski CS; Kowalska MA; Krajewski T; Janiak A
    Biochim Biophys Acta; 1982 Feb; 714(3):543-8. PubMed ID: 6277391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The platelet fibrinogen receptor.
    Peerschke EI
    Semin Hematol; 1985 Oct; 22(4):241-59. PubMed ID: 2996149
    [No Abstract]   [Full Text] [Related]  

  • 9. The binding of fibrinogen to its platelet receptor.
    Marguerie GA; Ardaillou N; Cherel G; Plow EF
    J Biol Chem; 1982 Oct; 257(20):11872-5. PubMed ID: 6288701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets.
    Dunn FW; Soria J; Soria C; Thomaidis A; Lee H; Caen JP
    Agents Actions Suppl; 1984; 15():97-104. PubMed ID: 6091425
    [No Abstract]   [Full Text] [Related]  

  • 12. Membrane receptors for fibrinogen and factor VIII and abnormalities of platelet function. A review.
    Di Minno G; Palladino M; Mattioli PL; Mancini M
    Haematologica; 1985; 70(4):354-7. PubMed ID: 3000900
    [No Abstract]   [Full Text] [Related]  

  • 13. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of fibrinogen with human platelets in a plasma milieu.
    Marguerie GA; Thomas-Maison N; Larrieu MJ; Plow EF
    Blood; 1982 Jan; 59(1):91-5. PubMed ID: 6274453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
    Timmons S; Kloczewiak M; Hawiger J
    Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
    Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of nucleotide affinity analog 5'-p-fluorosulfonylbenzoyladenosine with platelet ADP receptor: aggregin.
    Figures WR; Scearce LM; Colman RF; Colman RW
    Methods Enzymol; 1992; 215():143-55. PubMed ID: 1435320
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.